CHU Clermont-Ferrand
Clermont-Ferrand, 63000, France
NCT Number: NCT07121816
Palpitations are the cause of 16% of reasons for consultation with the general practitioner. 41% of palpitations are secondary to cardiac arrhythmia. If a rhythm or conduction disorder is recorded in a symptomatic context, then the cardiac origin can be validated or invalidated. The challenge therefore consists of obtaining an ECG trace during an attack of palpitations (per-critical ECG). Since patients are rarely symptomatic during consultations, additional exploration by ambulatory electrocardiographic recording is essential. To date, the 24-hour Holter ECG is currently the most used in current practice, only has a sensitivity of 22 to 35% maximum depending on the studies. We hypothesize that the ECG watch is a reliable medical tool in the etiological assessment of palpitations, with at least 90% of traces interpretable.
The main objective of this study is to validate the use of the ScanWatch watch (Withings®) in the assessment of palpitations.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Clermont-Ferrand, 63000, France
The following examinations will be carried out:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ECG watch in palpitation assessment
Time frame: One month
Time frame: One month
Time frame: One month
Time frame: One month
Device events Cardiovascular events
Contact information is provided by the study sponsor or research team.
University Hospital, Clermont-Ferrand
Other
Acronym: WATCH-RHYTHM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05821465
Arrhythmias, Cardiac, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial Details